Global Biodefense Market 2020-2030 by Product (Vaccines, Detection Devices, Antibiotics, Masks), Sales Channel, Application (Military, Civilian), and Region: Trend Forecast and Growth Opportunity

  • Licence Type:
  • Single User - $2980
  • Multi User - $4400
  • Enterprise User - $5800

Global biodefense market will reach $15.85 billion by 2030, growing by 6.2% annually over 2020-2030 owing to the rising need for military and civilian vaccines and equipment against diseases including COVID-19 pandemic. Highlighted with 84 tables and 73 figures, this 165-page report “Global Biodefense Market 2020-2030 by Product (Vaccines, Detection Devices, Antibiotics, Masks), Sales Channel, Application (Military, Civilian), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global biodefense market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global biodefense market in every aspect of the classification from perspectives of Product, Sales Channel, Application, and Region. Based on Product, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. Vaccines • Anthrax • Smallpox • Botulism • Nuclear/Radiation • E-Bola • Zika • Other Vaccines Biothreat Detection Devices • Detectors/Triggering Devices • Assays and Reagents • Samplers • Identifiers Antibiotics Masks Other Products Based on Sales Channel, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Online Sales • Offline Sales Based on Application, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Military • Civilian Geographically, the following regions together with the listed national/local markets are fully investigated: • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka) • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania) • North America (U.S., Canada, and Mexico) • South America (Brazil, Chile, Argentina, Rest of South America) • RoW (Saudi Arabia, UAE, South Africa) For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Product, Sales Channel, Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in global biodefense market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): Achaogen, Inc. Alexeter Technologies LLC Alnylam Pharmaceuticals, Inc. Altimmune, Inc. Bavarian Nordic AS BioFactura, Inc. Cleveland Biolabs, Inc. Dynavax Technologies Inc Dynport Vaccine Company LLC (DVC) Elusys Therapeutics, Inc. Emergent BioSolutions Inc General Dynamics Corp. GlaxoSmithKline Plc Ichor Medical Systems Mediimmune (AstraZeneca) Nanotherapeutics, Inc. Ology Bioscience PathSensors Inc Pluristem Therapeutics Sanofi Pasteur Ltd. SIGA Technologies, Inc. Soligenix, Inc. Xoma Corporation (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 8 1.1 Industry Definition and Research Scope 8 1.1.1 Industry Definition 8 1.1.2 Research Scope 9 1.2 Research Methodology 12 1.2.1 Overview of Market Research Methodology 12 1.2.2 Market Assumption 13 1.2.3 Secondary Data 13 1.2.4 Primary Data 13 1.2.5 Data Filtration and Model Design 15 1.2.6 Market Size/Share Estimation 16 1.2.7 Research Limitations 17 1.3 Executive Summary 18 2 Market Overview and Dynamics 20 2.1 Market Size and Forecast 20 2.2 Major Growth Drivers 21 2.3 Market Restraints and Challenges 24 2.4 Emerging Opportunities and Market Trends 27 2.5 Porter’s Fiver Forces Analysis 31 3 Segmentation of Global Market by Product 35 3.1 Market Overview by Product 35 3.2 Vaccines 37 3.2.1 Anthrax 40 3.2.2 Smallpox 41 3.2.3 Botulism 42 3.2.4 Nuclear/Radiation 43 3.2.5 E-Bola 44 3.2.6 Zika 45 3.2.7 Other Vaccines 46 3.3 Biothreat Detection Devices 47 3.4 Antibiotics 49 3.5 Masks 50 3.6 Other Products 51 4 Segmentation of Global Market by Sales Channel 52 4.1 Market Overview by Sales Channel 52 4.2 Online Sales 54 4.3 Offline Sales 55 5 Segmentation of Global Market by Application 56 5.1 Market Overview by Application 56 5.2 Military 58 5.3 Civilian 59 6 Segmentation of Global Market by Region 60 6.1 Geographic Market Overview 2019-2030 60 6.2 North America Market 2019-2030 by Country 64 6.2.1 Overview of North America Market 64 6.2.2 U.S. 68 6.2.3 Canada 72 6.2.4 Mexico 74 6.3 European Market 2019-2030 by Country 76 6.3.1 Overview of European Market 76 6.3.2 Germany 80 6.3.3 UK 82 6.3.4 France 84 6.3.5 Spain 86 6.3.6 Italy 88 6.3.7 Russia 90 6.3.8 Rest of European Market 92 6.4 Asia-Pacific Market 2019-2030 by Country 94 6.4.1 Overview of Asia-Pacific Market 94 6.4.2 Japan 98 6.4.3 China 101 6.4.4 Australia 103 6.4.5 India 105 6.4.6 South Korea 107 6.4.7 Rest of APAC Region 109 6.5 South America Market 2019-2030 by Country 111 6.5.1 Argentina 114 6.5.2 Brazil 116 6.5.3 Chile 118 6.5.4 Rest of South America Market 120 6.6 Rest of World Market 2019-2030 by Country 121 6.6.1 UAE 124 6.6.2 Saudi Arabia 126 6.6.3 South Africa 128 6.6.4 Other National Markets 130 7 Competitive Landscape 131 7.1 Overview of Key Vendors 131 7.2 New Product Launch, Partnership, Investment, and M&A 134 7.3 Company Profiles 135 Achaogen, Inc. 135 Alexeter Technologies LLC 137 Alnylam Pharmaceuticals, Inc. 138 Altimmune, Inc. 139 Bavarian Nordic AS 140 BioFactura, Inc. 141 Cleveland Biolabs, Inc. 142 Dynavax Technologies Inc 143 Dynport Vaccine Company LLC (DVC) 144 Elusys Therapeutics, Inc. 145 Emergent BioSolutions Inc 146 General Dynamics Corp. 147 GlaxoSmithKline Plc 148 Ichor Medical Systems 149 Mediimmune (AstraZeneca) 150 Nanotherapeutics, Inc. 151 Ology Bioscience 152 PathSensors Inc 153 Pluristem Therapeutics 154 Sanofi Pasteur Ltd. 155 SIGA Technologies, Inc. 156 Soligenix, Inc. 157 Xoma Corporation 158 8 Investing in Global Market: Risk Assessment and Management 159 8.1 Risk Evaluation of Global Market 159 8.2 Critical Success Factors (CSFs) 162 Related Reports and Products 165

Table 1. Snapshot of Global Biodefense Market, 2019-2030 19 Table 2. Main Product Trends and Market Opportunities in Global Biodefense Market 27 Table 3. Global Biodefense Market by Product, 2019-2030, $ mn 35 Table 4. Global Biodefense Market: Vaccines by Application, 2019-2030, $ mn 38 Table 5. List of Biodefense Vaccine Pipelines 39 Table 6. Global Biodefense Market: Vaccines Biothreat Detection Devices by Type, 2019-2030, $ mn 48 Table 7. Global Biodefense Market by Sales Channel, 2019-2030, $ mn 52 Table 8. Global Market by Application, 2019-2030, $ mn 56 Table 9. Global Biodefense Market by Region, 2019-2030, $ mn 61 Table 10. Leading National Biodefense Market, 2019 and 2030, $ mn 63 Table 11. North America Biodefense Market by Country, 2019-2030, $ mn 66 Table 12. U.S. Biodefense Market by Product, 2019-2030, $ mn 70 Table 13. U.S. Biodefense Market by Sales Channel, 2019-2030, $ mn 70 Table 14. U.S. Biodefense Market by Application, 2019-2030, $ mn 70 Table 15. Canada Biodefense Market by Product, 2019-2030, $ mn 73 Table 16. Canada Biodefense Market by Sales Channel, 2019-2030, $ mn 73 Table 17. Canada Biodefense Market by Application, 2019-2030, $ mn 73 Table 18. Mexico Biodefense Market by Product, 2019-2030, $ mn 75 Table 19. Mexico Biodefense Market by Sales Channel, 2019-2030, $ mn 75 Table 20. Mexico Biodefense Market by Application, 2019-2030, $ mn 75 Table 21. Europe Biodefense Market by Country, 2019-2030, $ mn 79 Table 22. Germany Biodefense Market by Product, 2019-2030, $ mn 81 Table 23. Germany Biodefense Market by Sales Channel, 2019-2030, $ mn 81 Table 24. Germany Biodefense Market by Application, 2019-2030, $ mn 81 Table 25. UK Biodefense Market by Product, 2019-2030, $ mn 83 Table 26. UK Biodefense Market by Sales Channel, 2019-2030, $ mn 83 Table 27. UK Biodefense Market by Application, 2019-2030, $ mn 83 Table 28. France Biodefense Market by Product, 2019-2030, $ mn 85 Table 29. France Biodefense Market by Sales Channel, 2019-2030, $ mn 85 Table 30. France Biodefense Market by Application, 2019-2030, $ mn 85 Table 31. Spain Biodefense Market by Product, 2019-2030, $ mn 87 Table 32. Spain Biodefense Market by Sales Channel, 2019-2030, $ mn 87 Table 33. Spain Biodefense Market by Application, 2019-2030, $ mn 87 Table 34. Italy Biodefense Market by Product, 2019-2030, $ mn 89 Table 35. Italy Biodefense Market by Sales Channel, 2019-2030, $ mn 89 Table 36. Italy Biodefense Market by Application, 2019-2030, $ mn 89 Table 37. Russia Biodefense Market by Product, 2019-2030, $ mn 91 Table 38. Russia Biodefense Market by Sales Channel, 2019-2030, $ mn 91 Table 39. Russia Biodefense Market by Application, 2019-2030, $ mn 91 Table 40. Biodefense Market in Rest of Europe by Country, 2019-2030, $ mn 93 Table 41. APAC Biodefense Market by Country, 2019-2030, $ mn 96 Table 42. Japan Biodefense Market by Product, 2019-2030, $ mn 100 Table 43. Japan Biodefense Market by Sales Channel, 2019-2030, $ mn 100 Table 44. Japan Biodefense Market by Application, 2019-2030, $ mn 100 Table 45. China Biodefense Market by Product, 2019-2030, $ mn 102 Table 46. China Biodefense Market by Sales Channel, 2019-2030, $ mn 102 Table 47. China Biodefense Market by Application, 2019-2030, $ mn 102 Table 48. Australia Biodefense Market by Product, 2019-2030, $ mn 104 Table 49. Australia Biodefense Market by Sales Channel, 2019-2030, $ mn 104 Table 50. Australia Biodefense Market by Application, 2019-2030, $ mn 104 Table 51. India Biodefense Market by Product, 2019-2030, $ mn 106 Table 52. India Biodefense Market by Sales Channel, 2019-2030, $ mn 106 Table 53. India Biodefense Market by Application, 2019-2030, $ mn 106 Table 54. South Korea Biodefense Market by Product, 2019-2030, $ mn 108 Table 55. South Korea Biodefense Market by Sales Channel, 2019-2030, $ mn 108 Table 56. South Korea Biodefense Market by Application, 2019-2030, $ mn 108 Table 57. Biodefense Market in Rest of APAC by Country, 2019-2030, $ mn 110 Table 58. South America Biodefense Market by Country, 2019-2030, $ mn 113 Table 59. Argentina Biodefense Market by Product, 2019-2030, $ mn 115 Table 60. Argentina Biodefense Market by Sales Channel, 2019-2030, $ mn 115 Table 61. Argentina Biodefense Market by Application, 2019-2030, $ mn 115 Table 62. Brazil Biodefense Market by Product, 2019-2030, $ mn 117 Table 63. Brazil Biodefense Market by Sales Channel, 2019-2030, $ mn 117 Table 64. Brazil Biodefense Market by Application, 2019-2030, $ mn 117 Table 65. Chile Biodefense Market by Product, 2019-2030, $ mn 119 Table 66. Chile Biodefense Market by Sales Channel, 2019-2030, $ mn 119 Table 67. Chile Biodefense Market by Application, 2019-2030, $ mn 119 Table 68. RoW Biodefense Market by Country, 2019-2030, $ mn 123 Table 69. UAE Biodefense Market by Product, 2019-2030, $ mn 125 Table 70. UAE Biodefense Market by Sales Channel, 2019-2030, $ mn 125 Table 71. UAE Biodefense Market by Application, 2019-2030, $ mn 125 Table 72. Saudi Arabia Biodefense Market by Product, 2019-2030, $ mn 127 Table 73. Saudi Arabia Biodefense Market by Sales Channel, 2019-2030, $ mn 127 Table 74. Saudi Arabia Biodefense Market by Application, 2019-2030, $ mn 127 Table 75. South Africa Biodefense Market by Product, 2019-2030, $ mn 129 Table 76. South Africa Biodefense Market by Sales Channel, 2019-2030, $ mn 129 Table 77. South Africa Biodefense Market by Application, 2019-2030, $ mn 129 Table 78. Achaogen, Inc.: Company Snapshot 135 Table 79. Achaogen, Inc.: Business Segmentation 135 Table 80. Achaogen, Inc.: Product Portfolio 136 Table 81. Achaogen, Inc.: Revenue, 2016-2018, $ mn 136 Table 82. Achaogen, Inc.: Recent Developments 136 Table 83. Risk Evaluation for Investing in Global Market, 2019-2030 160 Table 84. Critical Success Factors and Key Takeaways 163

Related Reports

Body Armor Market Size Report, Competitive Landscape, Regional Insight Status and Analytical Trend by 2031

Global Body Armor market was valued at approximately USD 2481.72 million in 2022, and is expected to reach around USD 4125.38 Million by end of 2031, growing at a CAGR of 5.81% during the period 2023-2031, according to Regal Intelligence. What the Report Offe ... read more

Category: Aerospace and Defence
Published: Oct 2023
Pages: 112
Single user Price: $2450
Ammunition Market Size Report, Competitive Landscape, Regional Insight Status and Analytical Trend by 2031

Global Ammunition market was valued at approximately USD 13584.2 million in 2022, and is expected to reach around USD 18628.41 Million by end of 2031, growing at a CAGR of 3.57% during the period 2023-2031, according to Regal Intelligence. What the Report Off ... read more

Category: Aerospace and Defence
Published: Oct 2023
Pages: 106
Single user Price: $2450
Pet Clothing Market Size Report, Competitive Landscape, Regional Insight Status and Analytical Trend by 2031

Global Pet Clothing market was valued at approximately USD 2512.7 million in 2022, and is expected to reach around USD 4067.77 Million by end of 2031, growing at a CAGR of 5.5% during the period 2023-2031, according to Regal Intelligence. What the Report Offe ... read more

Category: Aerospace and Defence
Published: Oct 2023
Pages: 101
Single user Price: $2450
Space Launch Market Size Report, Competitive Landscape, Regional Insight Status and Analytical Trend by 2031

Global Space Launch market was valued at approximately USD 13188.77 million in 2022, and is expected to reach around USD 37799.2 Million by end of 2031, growing at a CAGR of 12.41% during the period 2023-2031, according to Regal Intelligence. What the Report ... read more

Category: Aerospace and Defence
Published: Oct 2023
Pages: 106
Single user Price: $2450
Business Jets Market Size Report, Competitive Landscape, Regional Insight Status and Analytical Trend by 2031

Global Business Jets market was valued at approximately USD 22488.39 million in 2022, and is expected to reach around USD 44917.07 Million by end of 2031, growing at a CAGR of 7.99% during the period 2023-2031, according to Regal Intelligence. What the Report ... read more

Category: Aerospace and Defence
Published: Oct 2023
Pages: 101
Single user Price: $2450